ESC Professional Premium Access

Advances in ATTR amyloidosis

Event: ESC Congress 2022
Topic: Chronic Heart Failure
Session type: Advances in Science
Date: 27 August 2022
Time: 14:00 - 15:15

Congress Session

Become an ESC Professional member to access this resource

Become a member

Already a member? Sign in

4 presentations in this session

State-of-the-art lecture in ATTR amyloidosis.

Speaker: Professor M. Fontana (London, GB)
Thumbnail

Epidemiology of cardiac amyloidosis and burden on health care system in Germany: a retrospective analysis from 2009 to 2018

Speaker: Associate Professor R. Pfister (Cologne, DE)
Thumbnail

Value of the HFA-PEFF and H2FPEF scores in patients with heart failure and preserved ejection fraction caused by cardiac amyloidosis.

Speaker: Doctor D. Tomasoni (Brescia, IT)
Thumbnail

Plasma amyloid-beta in relation to cardiac function and risk of heart failure in the general population

Speaker: Mrs F. Zhu (Rotterdam, NL)
Thumbnail

4 speakers from this session

Professor Marianna Fontana

University College London, London (United Kingdom of Great Britain & Northern Ireland)
21 presentations
16 followers

Associate Professor Roman Pfister

Cologne University Hospital - Heart Center, Cologne (Germany)
0 follower

Doctor Daniela Tomasoni

University of Brescia, Brescia (Italy)
2 presentations
0 follower

Mrs Fang Zhu

Erasmus University Medical Centre, Rotterdam (Netherlands (The))
0 follower

This platform is supported by

logo Novo Nordisk